Testosterone administration in severe burns ameliorates muscle catabolism.
OBJECTIVE
To assess the effects of testosterone administration on muscle protein metabolism after severe burn injury. We hypothesized that restoration of blood testosterone concentrations would restore an important anabolic stimulus to skeletal muscle, and would further increase the anabolic response of muscle to amino acid supplementation.


METHODS
Pre- and postintervention trial conducted between September 1997 and July 1999.


METHODS
Burn intensive care unit.


METHODS
Six severely burned male patients (>70% total body surface area).


METHODS
Testosterone enanthate, 200 mg/wk (intramuscularly), for 2 wks.


RESULTS
Muscle protein synthesis, breakdown, and amino acid kinetics were determined. After a basal period in each study, we subsequently investigated the response to acute amino acid supplementation during enteral feeding. Total testosterone increased significantly from baseline to the low normal range after 1 wk, and to upper normal range after two injections (p <.001). Protein synthesis was unchanged, however, protein synthetic efficiency increased 2-fold (p <.01). Protein breakdown decreased almost 2-fold after testosterone enanthate (p <.05), resulting in an improvement in net amino acid balance to a value that was approximately zero (p <.0001). Amino acid supplementation at either time point provided no additional effects.


CONCLUSIONS
Restoration of blood testosterone can ameliorate the muscle catabolism of severe burn injury with normal feedings.
Ferrando
A A
AA
Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USA.
Sheffield-Moore
M
M
Wolf
S E
SE
Herndon
D N
DN
Wolfe
R R
RR
D000328:Adult; D001707:Biopsy, Needle; D002053:Burn Units; D002056:Burns / Q000175:diagnosis* / Q000188:drug therapy* / Q000601:surgery; D004734:Energy Metabolism; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D015601:Injury Severity Score; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins / Q000187:drug effects* / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D011336:Probability; D013739:Testosterone / Q000008:administration & dosage* / Q000031:analogs & derivatives; D016896:Treatment Outcome
D009124:Muscle Proteins; D013739:Testosterone; C004648:testosterone enanthate